The inactivation of CRL E3 ligases results in the accumulation of its substrates, and thereby leads to enhanced apoptosis in response to DNA damage, and MLN4924 has been reportedly applied in cancer therapy (62–65). The gene discussed is IL31RA; the disease is cancer.